New chemo combo shows promise in breast cancer fight
NCT ID NCT00433420
First seen May 05, 2026 · Last updated May 05, 2026
Summary
This study tested two different chemotherapy combinations in 2000 women with breast cancer that had spread to lymph nodes. The goal was to see if adding a drug called fluorouracil and giving treatments every 2 weeks (with a support drug to boost immune recovery) worked better than the standard 3-week schedule. The main focus was on how long women lived without the cancer coming back.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.